tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Alkem Laboratories’ Sikkim Facility Passes Armenian GMP Inspection

Story Highlights
  • Alkem Laboratories is a key player in pharmaceuticals, focusing on formulations and ingredients.
  • The Armenian GMP inspection at Alkem’s Sikkim facility ended with no major issues.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Alkem Laboratories’ Sikkim Facility Passes Armenian GMP Inspection

TipRanks Black Friday Sale

Alkem Laboratories Ltd. ( (IN:ALKEM) ) has provided an announcement.

Alkem Laboratories Ltd. announced that a recent Good Manufacturing Practice (GMP) inspection by the Ministry of Health, Armenia, at its Sikkim, India facility concluded without any critical or major observations. This successful inspection underscores Alkem’s commitment to maintaining high manufacturing standards, potentially enhancing its reputation and reliability in the pharmaceutical industry.

More about Alkem Laboratories Ltd.

Alkem Laboratories Ltd. is a prominent player in the pharmaceutical industry, specializing in the development, manufacture, and sale of pharmaceutical formulations and active pharmaceutical ingredients. The company focuses on providing a wide range of healthcare solutions and has a significant presence in both domestic and international markets.

Average Trading Volume: 7,893

Technical Sentiment Signal: Strong Buy

Current Market Cap: 681.7B INR

For detailed information about ALKEM stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1